CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Merck Sharp & Dohme Corp. et al. vs. Pfizer Inc.

๐Ÿ“ก 5G SEP โ€ข ETSI Declared

Explore the PTAB proceeding IPR2017-02136 filed by Merck Sharp & Dohme Corp. et al. on 2017-09-20. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-02136

Filing Date

2017-09-20

Accorded Filing Date

2017-09-20

Institution Decision Date

2018-03-22

Last Modified Date

2024-07-31

Proceeding Type

IPR

Termination Date

2019-03-13

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 14597488
Respondent Patent Number 9492559
Legal Expiration Date
2035-01-15 Active (8.2 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Emilio Anthony Emini et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

2 Total

Proceeding Status

Final Written Decision

Board Decisions & Rulings (2)

Vacated/Remanded 2024-04-29
Other: Fed Circuit mandate
35 U.S.C. Trial Decision
Termination 2019-03-13
FINAL WRITTEN DECISION AND RELATED ORDERS
35 USC 318, 37 CFR 42.73, 37 CFR 42.100

Address and Attorney/Agent Information

36 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Pfizer Inc. - Attn:Legal Patent Department, Chief IP Counsel
Customer Number 25291
Address 66 Hudson Boulevard East, New York, NY, 10001-2192, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
34462 Bryan Zielinski +1 858-755-5925
40784 Jeffrey Rennecker +1 858-622-8850
41213 Jeffrey Myers +1 212-733-5061
42640 Suzanne Bates +1 734-622-2658
43080 Lisa Samuels +1 860-686-0349
45051 Chase Romick +1 212-733-8054
46319 Christian Smolizza +1 212-733-9094
48032 John Wichtowski +1 860-715-6645

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 5 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (5 found):
PTAB: 5
USPTO PTAB Trial 2017-11-20
IPR2018-00188

Sanofi Pasteur inc. et al. v. Pfizer Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2017-11-20
IPR2018-00187

Sanofi Pasteur Inc. et al. v. Pfizer Inc.

Asserted Patent
Status: Final Written Decision - Appealed
USPTO PTAB Trial 2017-09-20
IPR2017-02138

Merck Sharp & Dohme Corp. et al. v. Pfizer Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-09-19
IPR2017-02132

Merck Sharp & Dohme Corp. et al. v. Pfizer Inc.

Asserted Patent
Status: Final Written Decision - Appealed
USPTO PTAB Trial 2017-09-19
IPR2017-02131

Merck Sharp & Dohme Corp. et al. v. Pfizer Inc.

Asserted Patent
Status: Final Written Decision - Appealed
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP โ€ข ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

โœ“ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
โœ“ Right to demand global FRAND portfolio determination.
โœ“ Non-discrimination defense: check licensing terms offered to competing implementers.

Proceeding Documents

200
57

Patent Owner Updated Mandatory Notice NOTICE

2024-05-09 FILING PARTY: PATENT OWNER
55

Other: Fed Circuit mandate OTHER

2024-04-29 FILING PARTY: BOARD
56

Other: other court decision OTHER

2024-04-29 FILING PARTY: BOARD
54

Patent Owner Updated Mandatory Notice Paper

2022-06-30 FILING PARTY: PATENT OWN
53

Patent Owner Amended Notice of Appeal Paper

2022-04-08 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc